SLNSW-Preplanned safety analysis of the JFMC37-0801 tri...-TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

Full title: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

Author/creator: Suto, Takeshi, Ishiguro, Megumi, Hamada, Chikuma, Kunieda, Katsuyuki, Masuko, Hiroyuki, Kondo, Ken, Ishida, Hideyuki, Nishimura, Genichi, Sasaki, Kazuaki, Morita, Takayuki, Hazama, Shoichi, Maeda, Koutarou, Mishima, Hideyuki, Ike, Hideyuki, Sadahiro, Sotaro, Sugihara, Kenichi, Okajima, Masazumi, Saji, Shigetoyo, Sakamoto, Junichi, Tomita, Naohiro.

Call Numbers:

Record Identifier: TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

Language: English

Formats: Articles

Publishers: Tokyo: Springer Japan

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    Record identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    Share

    Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    Full title

    Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    Author / Creator

    Suto, Takeshi ; Ishiguro, Megumi ; Hamada, Chikuma ; Kunieda, Katsuyuki ; Masuko, Hiroyuki ; Kondo, Ken ; Ishida, Hideyuki ; Nishimura, Genichi ; Sasaki, Kazuaki ; Morita, Takayuki ; Hazama, Shoichi ; Maeda, Koutarou ; Mishima, Hideyuki ; Ike, Hideyuki ; Sadahiro, Sotaro ; Sugihara, Kenichi ; Okajima, Masazumi ; Saji, Shigetoyo ; Sakamoto, Junichi ; Tomita, Naohiro

    Publisher

    Tokyo: Springer Japan

    Journal title

    International journal of clinical oncology, 2017, Vol.22 (3), p.494-504

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adjuvant chemotherapy Adjuvant treatment Adult Adverse events Aged Analysis Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - adverse effects Antimetabolites, Antineoplastic - therapeutic use Antimitotic agents Antineoplastic agents Cancer Cancer Research Capecitabine Capecitabine - administration & dosage Capecitabine - adverse effects Capecitabine - therapeutic use Chemotherapy Chemotherapy, Adjuvant - adverse effects Chemotherapy, Adjuvant - methods Clinical trials Colon cancer Colonic Neoplasms - drug therapy Colorectal cancer Dose-Response Relationship, Drug Feet Female Hand-foot syndrome Hand-Foot Syndrome - etiology Humans Hyperbilirubinemia Leukopenia Male Medicine Medicine & Public Health Middle Aged Neutropenia Oncology Original Original Article Product development Prognosis Surgical Oncology Treatment duration Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486458

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections